SHIZUKA SHISHIDO: Open Payments
NPI 1083641872 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 28 payments from 6 companies in 2025. Trend: 2023 $463 · 2024 $729 · 2025 $615
Food & beverage: $502Education: $112
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $195 |
| GENZYME CORPORATION | 6 | $182 |
| GlaxoSmithKline, LLC. | 14 | $179 |
| Optinose US, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $19 |
Products named: DUPIXENT, NUCALA, Xhance, ZEPBOUND, Ryaltris.
Industry payments across CA — which companies pay providers there.
